PLUS500 LTD (PLUS) — Research Note

Executive summary

Plus500 operates proprietary technology-based trading platforms, having transformed from a single CFD provider into a global multi-asset fintech group spanning OTC (CFDs), futures, prediction markets and share dealing across 17 regulatory licences. Revenue growth has reaccelerated from a cyclical trough (FY 2023 $725m) to upgraded FY 2026 consensus of $811.5m with H1 2026 revenue +12% YoY driven by a scaling US non-OTC business (+30% YoY to ~15% of group). The single most important point for valuation today: at ~10x forward earnings on a debt-free balance sheet with $861m cash (≈37% of market cap), the stock prices in minimal growth despite a demonstrably accelerating US franchise.

Fair value estimate

• Methodology: forward P/E on normalised earnings, triangulated against free-cash-flow yield.
• Key assumptions: FY 2026 consensus revenue $811.5m, EBITDA $365.1m, after D&A ($6m), FX/net financial ($3m) and 17% effective tax (12% Israeli PTE blended with international ops), FY 2026 net profit ~$295m. With ~68m weighted-average diluted shares post-buybacks, implied EPS $4.30 (£3.23 at 1.33 USD/GBP).
• Multiple range: 11x–15x — a reasonable band for a cash-generative, licence-moated fintech with a growing US franchise but genuine cyclicality.
• Fair value per share: 3,550p – 4,850p, midpoint ~4,200p.
• Implied market cap: £2,517m – £3,439m, midpoint ~£2,978m.
• Current market cap: £2,296.9m.
• Absolute upside to midpoint: ~30%.

Sector context

Confirmed: Financial Services / Financials (ICB). Plus500 sits above typical sector peers on quality (debt-free, 41-55% EBITDA margins, 99% cash conversion) and shareholder returns ($3.1bn since 2013 IPO, best FTSE All-Share total return at ~12,000%). Listed peers: IG Group (IGG.L), CMC Markets (CMCX.L), and increasingly Interactive Brokers (IBKR) on the institutional-execution side. Plus500 trades at a modest discount to IG Group despite a stronger balance sheet and faster non-OTC growth.

Investment thesis

• Deep valuation discount with real cash backing. EV/EBITDA of ~6x on FY 2026 consensus and ~$861m cash on balance sheet (37% of market cap) 2026-08 half-year. The business was the best-performing FTSE All-Share stock since IPO by TSR, yet trades near 52-week lows.
• US non-OTC business is a genuine growth engine, not a story. Revenue +30% YoY in H1 2026, now ~15% of group and on track for ~$140m annualised FY 2026, with blue-chip partnerships (CME Group, FanDuel, Wealthsimple, Nelogica) and prediction markets launched in Feb/Jun 2026 2026-08 half-year. Non-OTC provides diversification away from the cyclical CFD core.
• Capital return discipline is exceptional and continues. $370m announced in 2026 YTD (~16% of market cap in one year), with policy of at least 50% of net profit returned, 50%+ via buybacks 2026-08 half-year. Buyback at £43.55 average in H1 2026 implies management views current ~32p prices as a bargain.

Key risks

• Not an AI beneficiary. Business consumes AI (marketing tech, retention) but has no identifiable AI-driven revenue line or AI-expanded TAM. The AI thesis in this stock is absent, not weak [not disclosed but inferred].
• Volatility-dependent earnings. Customer Trading Performance was -$19m H1 2026 vs +$14m H1 2025, and interest income fell from $29.6m to $21.1m as rates ease 2026-08 half-year. Quieter markets or lower rates compress earnings materially.
• Regulatory risk from leveraged CFD exposure. 90% of OTC revenue is mobile-first retail trading in CFDs; historical ESMA/ASIC/FCA interventions have reset earnings before, and prediction markets attract regulatory scrutiny in the US 2026-08 half-year.

Operating leverage

Plus500 explicitly discloses ~70% of its cost base is variable — advertising/marketing tech ($80.9m in H1 2026), payment processing ($24.1m, scales with deposits), commissions ($44.6m, scales with non-OTC volumes), and data feeds 2026-08 half-year. Only ~30% is genuinely fixed (R&D payroll, central admin). This is deliberate — management touts cost-base flexibility as a strength. Consequently, operating leverage is moderate rather than high: a 10-20% revenue beat does not reliably multiply operating profit, because incremental revenue tends to be matched by scaled marketing spend to capture higher-value customers (H1 2026 incremental $16m marketing spend offset much of the top-line beat). EBITDA margin actually fell from 45% H1 2025 to 41% H1 2026 on 12% revenue growth — a tell that leverage is being reinvested, not dropped to the bottom line. Core proprietary tech platform is a true fixed cost that scales, but the acquisition engine's marketing-tech spend grows roughly with new-customer intake, muting the operating-leverage upside this investor is screening for.

Value-trap signals

• Core OTC/CFD business is in secular maturity — Active Customers declined from 2021 peaks and ARPU shift to higher-value is a quality offset, not a growth story.
• Customer Trading Performance line is lumpy and theoretically neutral but creates earnings noise that could repeatedly disappoint.
• Treasury shares now ~40% of issued capital — aggressive buyback-driven EPS support can mask absence of underlying unit growth.
• No major structural concerns: no related-party transactions, no auditor flags, no going-concern questions, no customer concentration.

Earnings vs. expectations

Pattern is clearly a serial beater:

• FY 2022: delivered revenue $832.6m / EBITDA $453.8m vs market expectations $757.7m/$345.8m type levels — material beat with multiple in-year upgrades.
• FY 2023: revenue ~$725m / EBITDA ~$340m "significantly ahead" of expectations $645m/$300m.
• FY 2024: revenue ~$768m / EBITDA ~$342m, "meaningfully ahead" of ~$724m/$338m consensus.
• FY 2025: revenue ~$792m / EBITDA ~$348m, ahead of ~$757.7m/$345.8m consensus.
• FY 2026 YTD: Q1 2026 ahead of expectations, consensus upgraded from $719m/$331m (Feb) → $779m/$360m (Apr) → $811.5m/$365.1m (Aug).

Beat frequency and magnitude are both high, consistent with low-ball management guidance culture.

Conviction

4 — high. Anchored by: (1) clean, well-disclosed IFRS financials with 99% cash conversion and a debt-free balance sheet; (2) a long, consistent track record of beats across diverse market conditions; (3) a widely-covered consensus providing a reliable earnings anchor. Limited by: (1) earnings sensitivity to macro volatility and Customer Trading Performance swings, which widens any point-estimate; (2) prediction markets and futures businesses are still early-stage and could inflect either direction. The call that it's cheap is high-confidence; the point estimate within a 3,500-4,800p range is less so.

Driver scoring

• ai_beneficiary (20): No material AI-receiver exposure. Trading platform business uses marketing/retention tech internally; neither the datasets nor the business model expand materially as agentic AI is adopted. Prediction markets are AI-adjacent only tangentially (speculation on AI outcomes, not AI infrastructure).
• operating_leverage (40): Management explicitly states ~70% variable cost base. Incremental revenue tends to be met with incremental marketing spend to capture higher-value cohorts. EBITDA margin compressed in H1 2026 despite 12% revenue growth — confirms moderate, not high, leverage.
• earnings_surprise_trend (82): Four consecutive years of beats with multiple upgrades per fiscal year. H1 2026 already saw multiple upward revisions.
• cyclicality (60): Trading volumes depend on market volatility; interest income (now ~5% of revenue) depends on rates. H1 2024 was softer with the Euros, Q3 2023 was weaker on calm markets.
• moat (55): 17 regulatory licences are a genuine barrier; proprietary tech stack and 34m registered customer base provide retention. But competitive industry (IG, CMC, eToro, Robinhood-adjacent); not dominant.
• leverage (5): Fortress — $861m cash, zero debt since inception, debt-free policy explicit.
• earnings_quality (72): Cash conversion 99%; clean IFRS; some noise from Customer Trading Performance but disclosed clearly; buybacks don't inflate reported EPS artificially (treasury shares excluded).
• management_quality (80): Best FTSE All-Share TSR since 2013. Disciplined M&A (Mehta India, Cunningham US, EZ Invest Japan — small, synergistic). $3.1bn returned to shareholders.
• growth_momentum (65): Reaccelerating — multiple 2026 upgrades, non-OTC +30%, prediction markets launched Feb 2026, Mehta integration adds India exposure.

Overall score: 505

Right valuation discipline (clear, cheap, well-covered balance sheet), right downside protection (net cash, consistent cash flow), right earnings quality — but wrong AI thesis and only moderate operating leverage. For an investor explicitly screening for AI-receiver exposure, Plus500 scores poorly on the single most heavily weighted driver (~35% of the overall rubric). It would be a solid value-plus-quality holding, but not a thesis-fit holding for this strategy. Scoring in the middle band — "worth knowing about" rather than "focus name."